Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial
- Lennie P.G. Derde (Primer Autor)
- , Anthony C. Gordon (Segundo Autor)
- , Paul R. Mouncey (Tercer Autor)
- , Farah Al-Beidh (Cuarto Autor)
- , Kathryn M. Rowan (Quinto Autor)
- , Luis Felipe Reyes
- , Alistair D. Nichol
- , Yaseen M. Arabi
- , Djillali Annane
- , Abigail Beane
- , Marc J.M. Bonten
- , Charlotte A. Bradbury
- , Frank M. Brunkhorst
- , Meredith Buxton
- , Allen C. Cheng
- , Matthew E. Cove
- , Michelle A. Detry
- , Lise J. Estcourt
- , Mark Fitzgerald
- , Herman Goossens
- Utrecht University
- The Intensive Care Center
- Imperial College London
- Intensive Care National Audit and Research Centre
- King Saud bin Abdulaziz University for Health Sciences
- Université Paris-Saclay
- Hôpital Raymond Poincaré
- University of Versailles Saint-Quentin-en-Yvelines
- University of Pittsburgh
- Mahidol Oxford Tropical Medicine Research Unit
- The Institute for Regeneration and Repair
- Mazankowski Heart Institute
- Critical Care Asia
- European Clinical Research Alliance on Infectious Diseases
- University of Bristol
- University of Edinburgh
- university of bristo
- Friedrich Schiller University Jena
- The Department of Anesthesiology and Intensive Care Medicine
- Global Coalition for Adaptive Research
- Monash University
- The School of Clinical Sciences
- The School of Public Health and Preventive Medicine
- Monash Health
- National University of Singapore
- National University Hospital
- Berry Consultants
- NHS Blood and Transplant
- University of Oxford
- University of Antwerp
- University of British Columbia
- REMAP-CAP
Producción científica: Contribución a una revista › Artículo › revisión exhaustiva
7
Citas
(Scopus)